When will Stendra become available as a generic?
Stendra (avanafil) is currently under patent protection, with its primary patents expected to expire around 2026 [1]. This expiration date is a crucial factor in determining when generic versions of the drug may become available.
What happens after Stendra's patents expire?
Once the patents protecting Stendra expire, other pharmaceutical companies will be able to manufacture and market generic versions of avanafil [2]. Generic drugs are chemically identical to their brand-name counterparts and are required to meet the same standards for safety, purity, and effectiveness [2].
How will generic Stendra impact drug pricing?
The introduction of generic alternatives typically leads to a significant decrease in drug prices due to increased competition [2]. This could make avanafil more affordable and accessible to a wider patient population.
How long does patent protection typically last for drugs?
In the United States, the patent term for a drug is generally 20 years from the date on which the patent application was filed [3]. However, various factors can extend or shorten this effective period of market exclusivity, such as patent term extensions to compensate for regulatory review time or patent litigation [3].
Who makes Stendra?
Stendra is manufactured by Vivus Pharmaceuticals [4].
What are the main patents for Stendra?
The primary patents associated with Stendra are expected to expire around 2026 [1]. Specific patent numbers and their expiration dates can be found on patent databases, such as those maintained by the U.S. Food and Drug Administration (FDA) and the United States Patent and Trademark Office (USPTO). DrugPatentWatch.com also tracks these patent expirations for various medications [1].
Can generic companies challenge Stendra's patents before expiration?
Yes, generic companies can challenge a drug's patents before their official expiration date through a process known as patent litigation [3]. These challenges can sometimes lead to earlier market entry for generic versions if the litigation is successful.
What is avanafil used for?
Avanafil is a medication used to treat erectile dysfunction (ED) [5]. It works by increasing blood flow to the penis during sexual stimulation [5].
How does avanafil compare to other ED medications?
Avanafil is a phosphodiesterase type 5 (PDE5) inhibitor, similar to other ED drugs like sildenafil (Viagra), tadalafil (Cialis), and vardenafil (Levitra) [5][6]. However, avanafil is known for its rapid onset of action, with some studies suggesting it can be effective as quickly as 15 minutes after taking the medication [5].
What are the side effects of avanafil?
Common side effects of avanafil include headache, flushing, nasal congestion, and back pain [5]. Less common side effects can also occur.
What is the regulatory status of generic Stendra?
Before a generic version of Stendra can be approved and marketed, the generic manufacturer must submit an Abbreviated New Drug Application (ANDA) to the FDA [2]. The FDA reviews the ANDA to ensure the generic drug is bioequivalent to the brand-name drug [2].
Sources:
1. DrugPatentWatch.com
2. U.S. Food and Drug Administration. (n.d.). Generic Drugs. Retrieved from [FDA website]
3. U.S. Food and Drug Administration. (n.d.). Patent Term Restoration. Retrieved from [FDA website]
4. Vivus Pharmaceuticals. (n.d.). Stendra. Retrieved from [Vivus Pharmaceuticals website]
5. Stendra Prescribing Information. (n.d.).
6. Sildenafil Prescribing Information. (n.d.).